Details of the Drug

General Information of Drug (ID: DMXRPUF)

Drug Name

NAN-101

Indication

Disease Entry	ICD 11	Status	REF
Congestive heart failure	BD10	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Gene therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT05598333) A Phase 2, Adaptive, Double-blinded, Placebo Controlled, Randomized, Multi-center Trial to Evaluate the Efficacy, Safety and Tolerability of Intracoronary Infusion of AB-1002 in Adult Subjects With New York Heart Association (NYHA) Class III Heart Failure and Non-ischemic Cardiomyopathy. U.S.National Institutes of Health.